C.Q. Pharmaceutical Holding Co., Ltd.

Shenzhen Stock Exchange 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd. Revenue for the year ending December 31, 2023: USD 11.28 B

C.Q. Pharmaceutical Holding Co., Ltd. Revenue is USD 11.28 B for the year ending December 31, 2023, a 14.81% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

C.Q. Pharmaceutical Holding Co., Ltd. Revenue for the year ending December 31, 2022 was USD 9.83 B, a -0.11% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. Revenue for the year ending December 31, 2021 was USD 9.84 B, a 42.03% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. Revenue for the year ending December 31, 2020 was USD 6.93 B, a 42.54% change year over year.
C.Q. Pharmaceutical Holding Co., Ltd. Revenue for the year ending December 31, 2019 was USD 4.86 B, a 29.54% change year over year.

Key data

Date	Revenue	Gross Profit	Operating Income	EBIT

Shenzhen Stock Exchange: 000950.SZ

C.Q. Pharmaceutical Holding Co., Ltd.

CEO	Mr. Wei Liu
IPO Date	Sept. 16, 1999
Location	China
Headquarters	No 1, Datong Road
Employees	14,485
Sector	Health Care
Industries Pharmaceuticals Drugstores & Retail Pharmacies

Description

C.Q. Pharmaceutical Holding Co., Ltd. distributes pharmaceutical products. Chongqing Medicines Co., Ltd. was formerly known as Southwest Branch of China Medicine Company. The company was founded in 1950 and is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. develops, manufactures, and distributes pharmaceuticals. The company is based in Chongqing, China. C.Q. Pharmaceutical Holding Co., Ltd. operates as a subsidiary of Chongqing Chemical & Pharmaceutical Holding Group Company

Key trends

Past 5 years